Skip to main content
American Journal of Lifestyle Medicine logoLink to American Journal of Lifestyle Medicine
. 2018 Oct 19;13(2):148–155. doi: 10.1177/1559827618806841

Lifestyle Change Alone Sufficient to Lower Cholesterol in Male Patient With Moderately Elevated Cholesterol: A Case Report

Walter J Janse Van Rensburg 1,
PMCID: PMC6378490  PMID: 30800020

Abstract

Background. Cardiovascular disease is a major cause of deaths. Elevated cholesterol levels to above the normal reference range is a major risk factor for developing cardiovascular disease. Current guidelines recommend the use of cholesterol-lowering drugs to lower cholesterol levels to within the normal reference range. However, the American Heart Association further recommends a change in lifestyle in managing cholesterol levels. Thus, cholesterol-lowering drugs may not be needed if a lifestyle-change alone is sufficient in lowering cholesterol levels to within normal ranges. Unfortunately, limited examples exist in academic literature to illustrate the effectiveness of lifestyle change alone in lowering of cholesterol levels. Case report. We report a case of a 33-year-old man, with moderately elevated cholesterol levels and a family history of cardiovascular disease. Method. The man followed an altered healthy fat diet accompanied with moderate exercise for 6 weeks, without the addition of cholesterol-lowering agents. Results. At the 6-week follow-up, he was able to decrease his total cholesterol by 40.25% and low-density lipid cholesterol by 52.8%, to within normal ranges. The cholesterol levels remained within normal ranges after 6 months. Conclusion. This case illustrates that in some individuals, lifestyle change alone is sufficient to lower moderately elevated cholesterol levels.

Keywords: hypercholesterolemia, lifestyle change, healthy fat diet


‘Statins may also result in a range of adverse effects, including muscle pain, diabetes mellitus, and central nervous system complaints, which might lead to noncompliant use by patients.’

Introduction

Diseases of the circulatory system are some of the leading causes of morbidity and mortality in South Africa, accounting for 17.8% of all deaths in South Africa in 2015. This is the second most common underlying cause of death, surpassed only by certain infectious and parasitic diseases. It is a worrying statistic because a slight increase of 1.1% has been seen in these deaths between 2013 and 2015. Diseases of the circulatory system include thrombosis-related disorders, such as stroke and heart attack. Cardiovascular diseases collectively accounted for 7.5% of deaths in South Africa in 2015. Thus, cardiovascular diseases remain a major cause of concern in South Africa.1 The World Heart Federation lists high cholesterol (hyperlipidemia), and especially elevated low-density lipid (LDL) cholesterol levels, as a major risk factor for developing cardiovascular disease. LDL cholesterol (“bad” cholesterol) accumulates in arteries, increasing the risk of heart attack and stroke. However, high-density lipid (HDL) cholesterol (“good” cholesterol) serves as a carrier, that helps remove cholesterol from the blood stream.2 HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors, called statins, are the most commonly used cholesterol-lowering drugs. The Blood Cholesterol Expert Panel from the American College of Cardiology and the American Heart Association (AHA) recommends that patients older than 21 years of age, with a LDL cholesterol level of more than 4.92 mmol/L be placed on high-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20 mg) to lower the LDL cholesterol levels by at least 50%.3 However, some controversy and debate has arisen subsequently to the publication of these recommendations, casting some doubt over the correct use of statins in treatment of elevated cholesterol.4 Nonetheless, it was found that these guidelines had little to no effect on the use of statins or LDL cholesterol levels in the clinical setting, with only a small increase (4%) in the statin intensity observed in patients treated for hypercholesterolemia.5 Statins may also result in a range of adverse effects, including muscle pain, diabetes mellitus, and central nervous system complaints, which might lead to noncompliant use by patients.6 Conversely, the AHA also recommends 4 lifestyle changes to help improve hyperlipidemia: (1) eating a heart-healthy diet, (2) regular exercise, (3) avoiding tobacco smoke, and (4) losing weight (if you are overweight or obese).7 Therefore, theoretically, a lifestyle change alone may be sufficient to lower elevated LDL cholesterol levels, without the use of cholesterol-lowering drugs, such as statins.

Case Report

A 33-year-old nonsmoking Caucasian man presented at his employer’s yearly wellness screening with a point-of-care nonfasting total cholesterol level of 8.5 mmol/L and was subsequently referred to his general practitioner (GP) for follow-up. The man has a family history of hypercholesterolemia and heart disease, with both his living parents on long-term cholesterol-lowering medications and a paternal grandfather who died of a myocardial infarction at 54 years. He has an office job, with a large amount of time spent sitting, with moderate physical activity after hours. The typical diet at presentation is given in Table 1. The case report was approved by the Health Sciences Research Ethics Committee of the University of the Free State (HSREC 133/2017, UFS-HSD2017/1265). The patient gave informed consent for the results to be published.

Table 1.

Typical Diet at Presentation.

Breakfast
Item Amount
Brown bread toast spread with butter or 60% buttermilk-containing margarine 1 Slice
Gouda or cheddar cheese 1 Slice
Espresso coffee (1 teaspoon sugar, dash of low-fat milk) 1 Cup
Lunch
Item Amount
Brown bread (sandwich buttered on both sides to toast) 2 Slices
Ham/salami 1 Slice
Gouda/cheddar cheese 1 Slice
Tomato ½ A tomato, sliced
Dinner
Item Amount
Protein ×1 Lasagna 250 g
Meat sauce 250 g
Baked battered fish 2 Pieces
Grilled chicken (skin on) 2 Pieces
Rump steak (fat retained) 200 g
Sausage 200 g
Lamb chops 200 g
Starch ×1 Potato bake 150 g
Potato mash 150 g
Oven-baked chips 150 g
Pasta (cooked) 1 Cup
White rice (cooked) 1 Cup
Fruit and vegetables ×2 (except the salads ×1) Steamed vegetables (broccoli, cauliflower, carrots, green beans, peas) 100-g Portions
Baked butternut ½ A butternut
Steamed gems squash ½ A squash
Fruit salad (paw-paw, pineapple, melon, watermelon, apple, banana, orange) Small salad bowl
Salad (lettuce, gherkins, tomatoes, cucumber, and feta cheese) Small salad bowl
Accompaniments
Item Amount
Mayonnaise 1-2 Tablespoons
Regular salad dressing 1-2 Tablespoons
Salt and pepper To taste
Cream to thicken meat sauces ½ Cup
Creamy béchamel sauce made with butter and low-fat milk ¼ Cup
Grated cheese ¼ Cup
Miscellaneous
Item Amount
Filter coffee (1 teaspoon sugar, dash of milk) 1 Cup
Dried high-fat sausage (“droëwors”) 50-100 g
Alcohol Moderate consumption (3-5 units per week)
Daily supplements
2 Capsules 1000 mg conjugated linoleic acid, 500 mg vitamin C, and 1 tablet Staminogro multivitamin

Anthropometric Values at Presentation

At presentation, the patient weighed 84.4 kg and, taken together with his height of 178 cm, had an overweight body mass index (BMI) of 26.64 kg/m2.

Fasting Lipogram at Presentation

The laboratory fasting lipogram results were as follows (normal reference ranges in brackets):

  • Total cholesterol 7.7 mmol/L (2.8-4.9 mmol/l)

  • Triglycerides 2.29 mmol/L (0.5-1.6 mmol/L)

  • HDL cholesterol 1.7 mmol/L (1.0-1.6 mmol/L)

  • LDL cholesterol 5.3 mmol/L (1.6-2.9 mmol/L)

  • Non-HDL cholesterol 6.0 mmol/L (0.8-3.7 mmol/L).

Medical Intervention

In consultation with the GP, it was decided to allow the patient to alter his lifestyle via diet and exercise and to perform a follow-up lipogram after 6 weeks, without prescribing any cholesterol lower drugs.

Altered Diet (Table 2)

Table 2.

Altered Diet.

Breakfast
Item Amount
Raw oats (boiled with 2/3 cup of water) 1/3 Cup
Salt To taste
Honey 1 Teaspoon
Ground cinnamon ½ Teaspoon
Espresso coffee (1 teaspoon sugar, dash of low-fat milk) 1 Cup
Midmorning Snack
Roasted, unsalted almonds 15
Lunch
Item Amount
High-kilojoule item ×1 Avocado ½ An avocado, sliced
Tuna in salt water 50 g
Skinless chicken breast 50 g
Sardines 50 g
Nonfat smooth cottage cheese 2 Tablespoons
Starch ×1 Brown bread spread with ProActive sterol-containing margarine (35% fat) 2 Slices
Whole wheat pasta (cooked) 1 Cup
Whole wheat wrap 1
Vegetables (any) Tomato ½ A tomato, sliced
Lettuce 1 Leaf
Cucumber 6 Rounds
Fresh peppers ¼ Cup
Cherry tomatoes 5
Fresh herbs (basil, coriander, parsley etc) To taste
Seasoning Salt and pepper To taste
Midafternoon Snack
Roasted, unsalted almonds 15
Dinner
Item Amount
Protein ×1 Skinless chicken breast 1
Ostrich 150 g
Lean venison 150 g
Unbattered fish 150 g
Lean pork fillet 150 g
Starch ×1 Baked jacket potato 1
Baked sweet potato 1
Lentils 1 Cup
Wild and brown rice (cooked) 1 Cup
Whole wheat pasta (cooked) 1 Cup
Whole wheat or brown burger bread roll 1
Whole wheat pita bread 1
Whole wheat burrito 1
Whole wheat couscous 1 Cup
Fruit and vegetables ×2 (except the salads ×1) Steamed/grilled vegetables (broccoli, cauliflower, carrots, green beans, peas) 100-g Portions
Baked butternut ½ A butternut
Steamed gems squash ½ A squash
Fruit salad (paw-paw, pineapple, melon, watermelon, apple, banana, orange) Small salad bowl
Salad (lettuce, tomatoes, cucumber, ½ avocado and 5 olives) Small salad bowl
Accompaniments
Item Amount
Fruit chutney 1-2 Tablespoons
Apple cider vinegar 1 Tablespoon
Reduced-oil salad dressing 1 Tablespoon
Preservative-free tomato sauce 1-2 Tablespoons
Reduced-oil mayonnaise 1 Tablespoon
Grated parmesan cheese 1 Teaspoon
Low-sodium salt and pepper To taste
Extra-virgin olive oil 1 Teaspoon
Preparation
Meat was fried, grilled, or baked in either avocado or olive oil. When cooking minced meat, low-fat vegetable stock was added to the sauce for flavor. Various beans were sometimes added to mince dishes to increase legume intake. Onions, garlic, ginger, and herbs were used to enhance flavor. Canned tomato mixes were used with caution because they sometimes contain extra added fats and sodium for taste
Miscellaneous
Item Amount
Filter coffee (1 teaspoon sugar, dash of milk) 1 Cup
Alcohol Moderate consumption (3-5 units per week)
>80% Dark chocolate 1 Piece
Daily Supplements
1 Capsule OmegaChoice EPA270/DHA180, 2 capsules 1000 mg conjugated linoleic acid, 500 mg vitamin C, and 1 tablet Staminogro multivitamin

The patient added clinically proven cholesterol-lowering foods to his daily diet, such as 1/3 cups raw oats, which is equivalent to roughly 1.3 g of oat β-glucan,8,9 30 g of almonds,10 at least half an avocado,11 and extra virgin olive oil.12 An omega 3 supplement was also added to the daily diet.13 The patient used conjugated linoleic acid (CLA), vitamin C, and a multivitamin as daily supplements prior to the altered diet. The effect of CLA on the blood lipid profile remains highly debated and largely inconclusive.14 However, because the patient already used a daily CLA supplement, it was decided to continue with 2000 mg CLA in order to limit the amount of variables taken away during the altered diet. Because 500 mg vitamin C per day has a proven positive impact on fat oxidation during moderate exercise,15 it remained as part of the altered lifestyle. The multivitamin (Staminogro) was previously recommended to the patient by his GP and is a combination of amino acids, antioxidants, B-complex vitamins, calcium, and other vitamins and minerals. An addition of a good multivitamin assists in maintaining a person’s nutrient status at optimal levels, and it was therefore continued.

Exercise

The patient exercised a minimum of 30 minutes, twice per week. The exercise included 10-minute cardio exercise (10 minutes treadmill at level 9/10-minute exercise stationary bicycle at resistance level 5/2-kilometre jog), and 20-minute high-intensity free weight routine (with minimal rest between sets).

Anthropometric Values at the 6-Week Follow-up

At follow-up, the patient weighed 77.3 kg, which gives a normal BMI of 24.40 kg/m2.

Fasting Lipogram at 6-Week Follow-up

The follow-up laboratory fasting lipogram results were as follows (baseline results in brackets):

  • Total cholesterol 4.6 mmol/L (7.7 mmol/l)

  • Triglycerides 0.9 mmol/L (2.29 mmol/L)

  • HDL cholesterol 1.9 mmol/L (1.7 mmol/L)

  • LDL cholesterol 2.5 mmol/L (5.3 mmol/L)

  • Non-HDL cholesterol 2.7 mmol/L (6.0 mmol/L)

Anthropometric Values at the 6-Month Follow-up

At follow-up, the patient weighed 68.2 kg, which gives a normal BMI of 21.50 kg/m2.

Fasting Lipogram at 6-Month Follow-up

The follow-up laboratory fasting lipogram results were as follows (baseline results in brackets):

  • Total cholesterol 4.6 mmol/L (7.7 mmol/l)

  • Triglycerides 0.9 mmol/L (2.29 mmol/L)

  • HDL cholesterol 1.7 mmol/L (1.7 mmol/L)

  • LDL cholesterol 2.8 mmol/L (5.3 mmol/L)

  • Non-HDL cholesterol 2.9 mmol/L (6.0 mmol/L)

Conclusion

The patient in this report was able to reduce his total cholesterol by 40.25% and his LDL cholesterol by 52.8% over the course of 6 weeks, without the use of cholesterol-lowering drugs. The altered diet reduced the amount of dairy and high animal fat foods, contained more lean meat, and increased the intake of food clinically proven to decrease LDL cholesterol (such as oats, almonds, avocados, and olive oil). After 6 months, the cholesterol levels remained constant within the normal range, and the patient stabilized his weight at a BMI of 21.50 kg/m2. It has been reported that weight loss in combination with a cholesterol-lowering diet is more effective in lowering LDL cholesterol levels than weight loss alone; therefore, the substantial decrease in LDL cholesterol in this case cannot be exclusively attributed to either the weight loss or diet but rather the combination of factors.16 Thus, it can be concluded that in some individuals with moderately high cholesterol levels, lifestyle changes (such as an altered, healthy fat diet and moderate exercise, together with weight loss) have the potential to lower cholesterol to within normal ranges without the addition of cholesterol-lowering drugs, such as statins.

Footnotes

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethical Approval: Ethical approval was granted by the Health Sciences Research Ethics Committee of the University of the Free State, HSREC 133/2017, UFS-HSD2017/1265.

Informed Consent: The patient gave consent for the results to be published.

Trial Registration: Not applicable, because this article does not contain any clinical trials.

ORCID iD: Walter J. Janse Van Rensburg Inline graphic https://orcid.org/0000-0001-9088-6199.

References

  • 1. Statistics South Africa. Mortality and causes of death in South Africa, 2015: findings from death notification. Statistical release P0309.3. https://www.statssa.gov.za/publications/P03093/P030932015.pdf. Published February 28, 2017. Accessed September 26, 2018.
  • 2. World Heart Federation. Cardiovascular risk factors. http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/cholesterol. Accessed May 22, 2017.
  • 3. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25, suppl 2):S1-S45. [DOI] [PubMed] [Google Scholar]
  • 4. Bansal M, Chandra KS. The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol management and for cardiovascular risk stratification: a reappraisal. Indian Heart J. 2014;66:1-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67:2395-2410. [DOI] [PubMed] [Google Scholar]
  • 6. Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ. Effect of 2013 ACC/AHA blood cholesterol guidelines on statin treatment patterns and low-density lipoprotein cholesterol in atherosclerotic cardiovascular disease patients. J Am Heart Assoc. 2017;6:e004909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. American Heart Association. Prevention and treatment of high cholesterol (hyperlipidemia). http://www.heart.org/HEARTORG/Conditions/Cholesterol/PreventionTreatmentofHighCholesterol/Prevention-and-Treatment-of-High-Cholesterol-Hyperlipidemia_UCM_001215_Article.jsp#.WSL0QNV96M8. Accessed May 22, 2017.
  • 8. Othman RA, Moghadasian MH, Jones PJH. Cholesterol-lowering effects of oat β-glucan. Nutr Rev. 2011;69:299-309. [DOI] [PubMed] [Google Scholar]
  • 9. Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100:1413-1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Jenkins DJA, Kendall CW, Marchie A, et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation. 2002;106:1327-1332. [DOI] [PubMed] [Google Scholar]
  • 11. Wang L, Bordi PL, Flemming JA, Hill AM, Kris-Etherton PM. Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial. J Am Heart Assoc. 2015;4:e001355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Violi F, Loffredo L, Pignatelli P, et al. Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects. Nutr Diabetes. 2015;5:e172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Shearer GC, Savinova OV, Harris WS. Fish oils—how does it reduce plasma triglycerides? Biochim Biophys Acta. 2012;1821:843-851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Benjamin S, Prakasan P, Sreedharan S, Wright ADG, Spener F. Pros and cons of CLA consumption: an insight from clinical evidences. Nutr Metab (Lond). 2015;12:4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Johnston CS, Corte C, Swan PD. Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adults. Nutr Metab (Lond). 2006;3:35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Le T, Flatt SW, Natarajan L, et al. Effects of diet composition and insulin resistance status on plasma lipid levels in a weight loss intervention in women. J Am Heart Assoc. 2016;5:e002771. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Lifestyle Medicine are provided here courtesy of SAGE Publications

RESOURCES